Skip to Content

Notice

Healthcare Infection Control Practices Advisory Committee (HICPAC): Meeting

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting.

Name: Healthcare Infection Control Practices Advisory Committee (Formerly Hospital Infection Control Practices Advisory Committee).

Times and Dates: 8:30 a.m.-5 p.m., November 6, 2000; 8:30 a.m.-4 p.m., November 7, 2000.

Place: Atlanta Marriott Century Center, 2000 Century Boulevard, NE, Atlanta, Georgia 30345.

Status: Open to the public, limited only by the space available.

Purpose: The Committee is charged with providing advice and guidance to the Secretary, the Assistant Secretary for Health, the Director, CDC, and the Director, National Center for Infectious Diseases (NCID), regarding (1) the practice of hospital infection control; (2) strategies for surveillance, prevention, and control of infections (e.g., nosocomial infections), antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of guidelines and other policy statements regarding prevention of healthcare associated infections and healthcare-related conditions.

Matters to be Discussed: Agenda items will include a review of proposed revisions to the Guideline for Prevention of Healthcare-associated Pneumonia, the Guideline for Isolation Precautions in Hospitals, the Guideline for Prevention of Intravascular Device-related Infections, the Guideline for Sterilization and Disinfection, the Guideline for Hand Hygiene, and the Guideline for Environmental Controls in Healthcare Settings; a discussion of the status of Staphylococcus aureus with Reduced Susceptibility to Vancomycin (VISA) in the United States; and updates on CDC activities of interest to the committee, including nosocomial tuberculosis control, the Federal Action Plan for Antimicrobial Resistance, and bioterrorism response in healthcare facilities.

Agenda items are subject to change as priorities dictate.

Contact Person for More Information: Michele L. Pearson, M.D., Executive Secretary, HICPAC, Hospital Infections Program, NCID, CDC, 1600 Clifton Road, NE, M/S A-07, Atlanta, Georgia 30333, telephone 404/639-6439.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Start Signature

Dated: September 28, 2000.

Carolyn J. Russell,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.

End Signature End Preamble

[FR Doc. 00-25685 Filed 10-5-00; 8:45 am]

BILLING CODE 4163-18-P